Lyme Disease Vaccine Market is valued at USD 26.7 Million in 2021 and expected to reach USD 135.9 Million by 2028 with a CAGR of 26.2% over the forecast period.
Lyme Disease Vaccine Market Size, Trends, Competitive, Historical & Forecast Analysis, 2022-2028, Increasing prevalence of Lyme disease infections, and growing clinical trials of new vaccines are major factors anticipated to drive the growth of the Global Lyme Disease Market.
Get Sample Report: https://brandessenceresearch.com/requestSample/PostId/1872
Scope of Global Lyme Disease Vaccine Market Report:
The Lyme disease, also known as Lyme borreliosis, is a vector-borne disease caused by the Borrelia bacterium, which is spread by ticks in the genus. Infected blacklegged ticks when bite to humans the disease is transmitted to humans. Lyme-causing bacteria can gradually travel from the tick’s gut to its salivary glands and then transmit the bacteria to the site of the bite. The symptoms of the disease include fatigue, fever, headache and skin rash. If left untreated, it can spread to heart, nervous system and joints and can be lethal. The vaccine for Lyme disease is under pipeline. Mostly endemic areas people has acquire Lyme disease. Lyme disease vaccination is the best way to protect against the mounting threat of tick-borne diseases.
The Covid-19 pandemic has shown A significant impact on global lyme diseases vaccine market. The Covid-19 outbreak caused stressful situation amongst healthcare industry as WHO declared it pandemic. The vaccine development against covid-19 was the most essential thing during initial stage during pandemic. The bacterial vaccines such as DNA vaccines and clinical trials of various DNA vaccines for Covid-19 are carried out which has been positively impacted the global Lyme disease vaccine market.
The global Lyme disease vaccine market is segmented into on the basis of type, application and region & country level. On the basis of type, the global Lyme disease vaccine market is classified into inactivated vaccine and attenuated vaccine. Based upon application, the global Lyme disease vaccine market is divided into hospital, scientific research and others.
Global Lyme Disease Vaccine Market Segmentation:
- Inactivated Vaccine
- Attenuated Vaccine
- Scientific Research
The regions covered in global lyme diseases Vaccine market report are North America, Europe, Asia-Pacific, Latin America and Rest of the World. On the basis of country level, the market of global lyme diseases vaccine market is subdivided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, India, Japan, South East Asia, Middle East Asia (UAE, Egypt, Saudi Arabia) GCC, Africa, etc.
Key Players of Global Lyme Disease Vaccine Market:
Some of the key players for global Lyme disease vaccine market are:
- Sanofi Pasteur SA
- Hualan Biological Engineering
- Janssen Pharmaceuticals
- Bharat Biotech International
- Serum Institute of India Pvt
News: Yale Researchers Developed mRNA-Based Lyme Disease Vaccine
On December 17th, 2021; Yale University researchers developed a completely exceptional vaccine that in guinea pigs presents safety against infection by the bacterium that causes Lyme disease and should also battle other tick-borne diseases. As an alternative of triggering an immune reaction against a precise pathogen, the innovative vaccine prompts a quick response inside the skin to components of tick saliva, preventive the quantity of time that ticks require to feed on and contaminate the host. The vaccine is delivered by the similar mRNA technology that has proved so helpful against Covid-19.
Newly Developed Vaccine Could Prevent Lyme Disease
On March 2nd, 2021; University of Massachusetts School of medicine had developed a new vaccine that could avoid Lyme disease in humans. The vaccination against the tick-borne disease received federal approval previous year and is now a part of an early clinical test. Work on the vaccine is being spearheaded by Dr. Mark Klempner, a associate of the school’s biologics program who has been performing on a Lyme cure for a decade. The vaccine is being tested on 66 patients in Nebraska, Lincoln, and could be accessible to the public in the spring of 2023.
Increasing Prevalence of Lyme Disease Infections, and Growing Clinical Trials of New Vaccines are Driving the Growth of the Global Lyme Disease Market
North America is Expected to Dominate the Global Lyme Disease Vaccine Market
North America is expected to dominate the global Lyme disease vaccine market due to the increasing prevalence of Lyme disease, research and development in vaccines and highly developed healthcare infrastructure in this region.
This comprehensive report will provide:
- Enhance your strategic decision making
- Assist with your research, presentations, and business plans
- Show which emerging market opportunities to focus on
- Increase your industry knowledge
- Keep you up-to-date with crucial market developments
- Allow you to develop informed growth strategies
- Build your technical insight
- Illustrate trends to exploit
- Strengthen your analysis of competitors
- Provide risk analysis, helping you avoid the pitfalls other companies could make
- Ultimately, help you to maximize profitability for your company.
Our Market Research Solution Provides You Answer to Below Mentioned Question:
- Which are the driving factors responsible for the growth of the market?
- Which are the roadblock factors of this market?
- What are the new opportunities, by which market will grow in coming years?
- What are the trends of this market?
- Which are the main factors responsible for new product launches?
- How big are the global & regional markets in terms of revenue, sales, and production?
- How far will the market grow in the forecast period in terms of revenue, sales, and production?
- Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
- How will each segment grow over the forecast period and how much revenue will these segments account for in 2028?
- Which region has more opportunities?
Get Access to the Full Report Here: https://brandessenceresearch.com/vaccines/lyme-disease-vaccine-market
The Global Surgical Instrument Tracking Systems Market in terms of revenue was worth of USD 193.8 Million in 2021 and is Projected to reach USD 513.1 Million by 2028, growing at a CAGR of 14.92% from 2021 to 2027.
Animal Vaccine Market was worth of USD 11.13 billion in 2021 and it is expected to reach 20.48 billion by the end of 2028 with the CAGR of 9.1% during Forecast Period.
Hemophilia Gene Therapy Market is valued at USD 331.4 Million in 2021 and expected to reach USD 4092.6 Million by 2028 with a CAGR of 43.2% over the forecast period.
Global Bioinformatics Market in terms of revenue was worth of USD 10.82 Billion in 2021 and expected to reach USD 24.07 Billion by 2028, growing at a CAGR of 12.1% from 2021 to 2028.
Colorectal Cancer Market is valued at USD 11.83 Billion in 2021 and is expected to reach USD 16.21 Billion by 2028 with a CAGR of 5.40% over the forecast period.
Global Medical Tricorder Market is valued at USD 3425.4 Million in 2021 and is expected to reach USD 5411.2 Million by 2028 with a CAGR of 6.75% over the forecast period.
Global Healthcare CRM Market is valued at USD 12.53 Billion in 2021 and is expected to reach USD 31.54 Billion by 2028 with a CAGR of 14.1% over the forecast period.
The Global Metaverse in Healthcare Market is valued at USD 5056.4 Million in 2021 and is expected to reach USD 7453.6 Million by 2028 with a CAGR of 33.7% over the forecast period.
Global Demand For Advanced Wound Care Market, in terms of revenue, was estimated to be USD 9.01 billion in 2018 and is expected to reach USD 13.27 billion in 2025, growing at a CAGR of 5.85% from 2019 to 2025.
According to Brandessence Market Research latest research study says Global demand for biophotonics market size in terms of revenue, was worth of USD 53.28 Billion in 2020. The biophotonics market is likely to reach USD 109.23 Billion by 2027 end, growing at a robust 10.8% CAGR.
The Global Sterility Testing Market in terms of revenue was worth of USD 1036.13 Million in 2021 and expected to reach USD 2193.8 Million by 2028, growing at a CAGR of 12.6% from 2021 to 2028.
i-Factor: Live Market intelligence platform
I-Factor is our guaranteed seal to keep our clients ahead of the competition, always. This knowledge platform delivers real-time updates on key economic indicators, competitive landscape, changing demand, trends, customized regional insights, and more. The platform visualizes key data points to help make decision making agile, trustworthy, and holistic. Register for free trial here at https://brandessenceresearch.com/i-factor/login/userRegister
Brandessence Market Research & Consulting Pvt ltd.
Brandessence Market Research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.
Mr. Vishal Sawant
Corporate Sales: +44-2038074155
Asia Office: +917447409162